Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001372
Filing Date
2021-08-12
Accepted
2021-08-12 16:22:43
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20210630.htm   iXBRL 10-Q 2276791
2 EX-31.1 glue-20210630ex31_1.htm EX-31.1 16276
3 EX-31.2 glue-20210630ex31_2.htm EX-31.2 16270
4 EX-32.1 glue-20210630ex32_1.htm EX-32.1 9527
5 EX-32.2 glue-20210630ex32_2.htm EX-32.2 9523
  Complete submission text file 0000950170-21-001372.txt   6456759

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glue-20210630_pre.xml EX-101.PRE 260880
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glue-20210630_lab.xml EX-101.LAB 323572
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glue-20210630_cal.xml EX-101.CAL 24689
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glue-20210630_def.xml EX-101.DEF 134578
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glue-20210630.xsd EX-101.SCH 36581
11 EXTRACTED XBRL INSTANCE DOCUMENT glue-20210630_htm.xml XML 922777
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40522 | Film No.: 211167901
SIC: 2836 Biological Products, (No Diagnostic Substances)